Diligence memo · auto-generated · as of July 2, 2026
Evolutionary Genomics, Inc.
Evolutionary Genomics, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Evolutionary Genomics, Inc. operates in Agriculture, based in CASTLE ROCK.
Sub-sector tags: biotech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Evolutionary Genomics, Inc. has raised $4.4M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.9M on 2016-02-22.
Most recent recorded round closed around 2022-03-24.
Valuation (modeled)modeled
Provath models Evolutionary Genomics, Inc. at approximately $6.5M (range $858K–$32M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.71× the median modeled value of Seed Agriculture companies in 2022–2024 (51 peers) — value vs value, same stage and era. Within the normal band (71% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 37 months.
Last raise 4.3 yr ago; this sector typically re-raises about every 11 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 2.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 65% of Agriculture peers (1056 compared).
Modeled value ranks above 37% of those peers.
Closest niche peers: Green Mountain Investments, LLC, Dalan Animal Health, Inc., Babylon Micro-Farms Inc., Jensen Ranch, LLC, American Ostrich Company, LLC.
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.